246 related articles for article (PubMed ID: 36980727)
21. Zymosan promotes proliferation,
Chen X; Luo Q; Ding J; Yang M; Zhang R; Chen F
Infect Agent Cancer; 2020; 15():51. PubMed ID: 32760436
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA PVT1 promotes tumor cell proliferation, invasion, migration and inhibits apoptosis in oral squamous cell carcinoma by regulating miR‑150‑5p/GLUT‑1.
Li X; Ren H
Oncol Rep; 2020 Oct; 44(4):1524-1538. PubMed ID: 32945498
[TBL] [Abstract][Full Text] [Related]
23. Nerve-tumour interaction enhances the aggressiveness of oral squamous cell carcinoma.
Lee TL; Chiu PH; Li WY; Yang MH; Wei PY; Chu PY; Wang YF; Tai SK
Clin Otolaryngol; 2019 Nov; 44(6):1087-1095. PubMed ID: 31574203
[TBL] [Abstract][Full Text] [Related]
24. High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.
Xie GF; Zhao LD; Chen Q; Tang DX; Chen QY; Lu HF; Cai JR; Chen Z
Drug Des Devel Ther; 2020; 14():1717-1727. PubMed ID: 32440097
[TBL] [Abstract][Full Text] [Related]
25. A Comparison of the Characteristics of Cytokine Storm between Lichen Planus and Oral Squamous Cell Carcinoma.
Kalbassi S; Radfar L; Azimi M; Shadanpoor S; Ghorbani Ranjbary A
Asian Pac J Cancer Prev; 2022 Nov; 23(11):3843-3849. PubMed ID: 36444597
[TBL] [Abstract][Full Text] [Related]
26. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
27. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
28. Increased tumor-infiltrating plasmacytoid dendritic cells predicts poor prognosis in oral squamous cell carcinoma.
Han N; Zhang Z; Liu S; Ow A; Ruan M; Yang W; Zhang C
Arch Oral Biol; 2017 Jun; 78():129-134. PubMed ID: 28242507
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinoma.
Skrinjar I; Brailo V; Vidovic-Juras D; Vucicevic-Boras V; Milenovic A
Med Oral Patol Oral Cir Bucal; 2015 Jul; 20(4):e402-7. PubMed ID: 25858079
[TBL] [Abstract][Full Text] [Related]
30. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
31. MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients.
Mazumder S; Basu B; Ray JG; Chatterjee R
Arch Oral Biol; 2023 Mar; 147():105627. PubMed ID: 36657275
[TBL] [Abstract][Full Text] [Related]
32. Salivary IL-8, IL-6 and TNF-α as Potential Diagnostic Biomarkers for Oral Cancer.
Sahibzada HA; Khurshid Z; Khan RS; Naseem M; Siddique KM; Mali M; Zafar MS
Diagnostics (Basel); 2017 Apr; 7(2):. PubMed ID: 28397778
[TBL] [Abstract][Full Text] [Related]
33. GATA6‑induced FN1 activation promotes the proliferation, invasion and migration of oral squamous cell carcinoma cells.
Zhai J; Luo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35088888
[TBL] [Abstract][Full Text] [Related]
34. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
35. Alkannin restrains oral squamous carcinoma cell growth, migration and invasion by regulating microRNA-9/RECK axis.
Mao Y; Zhang W; Zhang R; Zuo J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3153-3162. PubMed ID: 31349748
[TBL] [Abstract][Full Text] [Related]
36. Gα₁₂ drives invasion of oral squamous cell carcinoma through up-regulation of proinflammatory cytokines.
Jian SL; Hsieh HY; Liao CT; Yen TC; Nien SW; Cheng AJ; Juang JL
PLoS One; 2013; 8(6):e66133. PubMed ID: 23762476
[TBL] [Abstract][Full Text] [Related]
37. Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge.
Petruzzi MN; Cherubini K; Salum FG; de Figueiredo MA
Diagn Pathol; 2017 Apr; 12(1):32. PubMed ID: 28381274
[TBL] [Abstract][Full Text] [Related]
38. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
Wang Y; Jiang Y; Chen L
J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
[TBL] [Abstract][Full Text] [Related]
39. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
[No Abstract] [Full Text] [Related]
40. The balance of serum IL-18/IL-37 levels is disrupted during the development of oral squamous cell carcinoma.
Ding L; Zhao X; Zhu N; Zhao M; Hu Q; Ni Y
Surg Oncol; 2020 Mar; 32():99-107. PubMed ID: 31983439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
